Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD: A Pilot Double-blind, Randomized Clinical Trial

NCT04759703 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04759703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04759703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD: A Pilot Double-blind, Randomized Clinical Trial
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2/3
Overall status
Terminated
Start date
January 24, 2022
Completion date
May 24, 2024
Enrollment
75 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

opioid withdrawal, opioid-use disorder, restless legs syndrome, sleep disorder